TWC
ALNY icon

TD Waterhouse Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History

TD Waterhouse Canada’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Sell
1,825
-146
-7% -$44K ﹤0.01% 850
2026
Q1 		$647K Buy
1,971
+1,641
+497% +$558K ﹤0.01% 780
2025
Q4 		$131K Hold
330
– – ﹤0.01% 978
2025
Q3 		$152K Buy
330
+300
+1,000% +$122K ﹤0.01% 934
2025
Q2 		$9.65K Hold
30
– – ﹤0.01% 1461
2025
Q1 		$7.64K Hold
30
– – ﹤0.01% 1455
2024
Q4 		$7.06K Hold
30
– – ﹤0.01% 1479
2024
Q3 		$8.26K Sell
30
-806
-96% -$210K ﹤0.01% 1395
2024
Q2 		$203K Sell
836
-9
-1% -$1.42K ﹤0.01% 764
2024
Q1 		$131K Buy
845
+31
+4% +$5.17K ﹤0.01% 848
2023
Q4 		$159K Sell
814
-26
-3% -$4.43K ﹤0.01% 721
2023
Q3 		$154K Sell
840
-50
-6% -$9.54K ﹤0.01% 684
2023
Q2 		$172K Sell
890
-41
-4% -$8.13K ﹤0.01% 686
2023
Q1 		$191K Sell
931
-4
-0.4% -$841 ﹤0.01% 660
2022
Q4 		$223K Sell
935
-199
-18% -$42.4K ﹤0.01% 632
2022
Q3 		$227K Sell
1,134
-1,678
-60% -$320K ﹤0.01% 646
2022
Q2 		$422K Sell
2,812
-35
-1% -$4.96K ﹤0.01% 576
2022
Q1 		$489K Sell
2,847
-29
-1% -$4.42K ﹤0.01% 595
2021
Q4 		$482K Buy
+2,876
New +$535K ﹤0.01% 614

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's ALNY Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Alnylam Pharmaceuticals (ALNY) stake by 7.4% in Q2 2026, selling an estimated $44K and leaving 1,825 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

TD Waterhouse Canada first reported a position in ALNY in Q4 2021 and has held it in 19 quarters since. The position peaked at $647K in Q1 2026. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • TD Waterhouse Canada held 1,825 shares of Alnylam Pharmaceuticals worth $551K as of Q2 2026.
  • TD Waterhouse Canada sold 146 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $44K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #850 holding.
  • TD Waterhouse Canada first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Alnylam Pharmaceuticals position peaked at $647K in Q1 2026.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.